Nobel Laureate Frances Arnold Brings Directed Evolution to Angelman Syndrome Research
Nobel laureate Dr. Frances Arnold receives FAST funding to engineer new molecular tools for durable RNA-targeted therapies, bringing world-class expertise to Angelman syndrome research.
Non-viral delivery gene editing takes an important step forward for Angelman syndrome
A FAST-funded study unveils STEP-RNP, a non-viral gene editing platform showing improved motor, cognitive function in AS mice—an early but promising step toward treating Angelman syndrome.